BXM Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Buy
+5,350
New +$307K 0.17% 128
2025
Q4
Sell
-4,550
Closed -$205K 139
2025
Q3
$205K Buy
+4,550
New +$212K 0.19% 126

Other funds holding BMY

BXM Wealth's BMY Position: Q2 2026 in Review

BXM Wealth opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 5,350 shares worth $308K. The stake represents 0.17% of the portfolio and ranks #128 among its holdings. This is a return to the name: BXM Wealth previously reported a position in BMY as recently as Q3 2025.

BXM Wealth first reported a position in BMY in Q3 2025 and has held it in 2 quarters since. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • BXM Wealth held 5,350 shares of Bristol-Myers Squibb worth $308K as of Q2 2026.
  • Bristol-Myers Squibb was a new BXM Wealth position in Q2 2026.
  • Bristol-Myers Squibb made up 0.17% of BXM Wealth's portfolio in Q2 2026, its #128 holding.
  • BXM Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 2 quarters since.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on BXM Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.